AC Immune SA Income Statement

Income Statement Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024 Sep2025
Revenue & cost
Revenue 33.12M0.67M23.21M20.53M7.07M111.65M17.07M0.74M4.08M16.69M31.17M28.67M
Gross Profit 32.55M0.02M22.47M20.53M7.07M110.32M15.27M-1.06M4.08M16.69M31.17M28.67M
Operating items
Depreciation & Amortization - Total -0.29M-0.28M-0.59M-0.98M0.42M0.48M0.56M
Research & Development -17.63M17.23M25.77M33.11M45.28M50.96M65.82M68.16M62.63M61.56M71.43M
Share-based Compensation (IS) 3.41M2.96M3.46M3.69M
Selling, General & Administrative -3.76M3.45M7.90M10.27M12.75M16.27M20.57M19.60M16.39M17.25M19.70M
Other Operating Expenses 0.00M0.29M0.28M0.59M0.29M0.58M1.50M1.29M1.39M1.68M0.16M
Operating Expenses -21.39M20.68M33.67M43.38M57.74M66.60M84.83M86.46M77.63M77.14M90.96M
Operating Income 11.73M18.82M-10.46M-22.85M-50.68M45.00M-67.76M-86.46M-73.54M-60.45M-59.79M
EBIT 11.73M18.82M-10.46M-22.85M-50.68M45.00M-67.76M-86.46M-73.54M-60.45M-59.79M
Non-operating items
Interest & Investment Income 0.02M1.61M3.32M0.33M0.13M0.31M0.09M7.10M0.07M1.18M3.65M
Other Non Operating Income 1.61M3.44M-4.10M-1.22M-2.03M-0.61M0.12M0.41M-1.65M-1.82M
Non Operating Income 0.03M1.66M3.36M-3.92M-1.43M0.92M-0.73M6.58M0.11M-0.68M1.67M
Net income details
EBT 11.76M20.48M-7.10M-26.77M-52.11M45.91M-68.49M-79.88M-73.43M-61.13M-58.12M
Tax Provisions 0.00M0.01M0.01M0.00M
Profit After Tax 11.76M20.48M-7.10M-26.77M-52.11M45.91M-68.49M-79.88M-73.44M-61.14M-58.12M
Income from Continuing Operations 11.76M20.48M-7.10M-26.77M-52.11M45.91M-68.49M-79.88M-73.44M-61.14M-58.12M
Consolidated Net Income 11.76M20.48M-7.10M-26.77M-52.11M45.91M-68.49M-79.88M-73.44M-61.14M-58.12M
Income towards Parent Company 11.76M20.48M-7.10M-26.77M-52.11M45.91M-68.49M-79.88M-73.44M-61.14M-58.12M
Net Income towards Common Stockholders 11.76M20.48M-7.10M-26.77M-52.11M45.91M-68.49M-79.88M-73.44M-61.14M-58.12M
Additional items
EPS (Basic) 0.00M0.00M-0.00M-0.00M-0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) 0.00M0.00M-0.00M-0.00M-0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 55.40M56.77M56.77M67.56M71.86M71.94M72.89M84.46M84.72M99.84M100.63M
Shares Outstanding (Diluted Average) 49.84M46.04M50.10M57.86M
EBITDA 11.73M18.53M-10.73M-23.43M-51.66M45.42M-67.29M-85.91M-73.54M-60.45M-59.79M